We are live on ! Find out more
KNSA icon

Kiniksa Pharmaceuticals
KNSA

62 hedge funds and large institutions have $167M invested in Kiniksa Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 25 increasing their positions, 11 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 11

80% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 10

26% more capital invested

Capital invested by funds: $132M → $167M (+$34.9M)

15% more funds holding

Funds holding: 54 → 62 (+8)

2.3% less ownership

Funds ownership: 81.05% → 78.75% (-2.3%)

Holders
62
Holders Change
+8
Holders Change %
+14.81%
% of All Funds
1.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
25
Reduced
11
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
+$4.15M
2
GTC
Ghost Tree Capital
New York
+$3.04M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$2.69M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$2.07M
5
Millennium Management
Millennium Management
New York
+$1.82M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.8M
2
VMI
VHCP Management II
New York
-$4.6M
3
VMI
VHCP Management III
New York
-$2.36M
4
Victory Capital Management
Victory Capital Management
Texas
-$2.02M
5
BlackRock
BlackRock
New York
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
SSA
26
Schonfeld Strategic Advisors
New York
$430K +$338K +38,900 New
N
27
Nuveen
North Carolina
$409K -$32.8K -3,770 -9%
HF
28
HRT Financial
New York
$357K +$281K +32,300 New
Charles Schwab
29
Charles Schwab
California
$337K -$51.8K -5,964 -16%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$295K +$232K +26,690 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$236K -$1.49K -171 -0.8%
AllianceBernstein
32
AllianceBernstein
Tennessee
$212K – – –
UBS Group
33
UBS Group
Switzerland
$210K +$83.5K +9,604 +103%
CS
34
Credit Suisse
Switzerland
$204K +$4K +460 +3%
Barclays
35
Barclays
United Kingdom
$202K +$59.6K +6,864 +60%
Two Sigma Investments
36
Two Sigma Investments
New York
$201K +$158K +18,211 New
LI
37
Leap Investments
Illinois
$191K +$150K +17,232 New
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$187K +$2.91K +335 +2%
M&T Bank
39
M&T Bank
New York
$180K +$24.4K +2,808 +21%
CSS
40
Cubist Systematic Strategies
Connecticut
$174K +$133K +15,363 +4,492%
Goldman Sachs
41
Goldman Sachs
New York
$150K -$392K -45,091 -77%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$150K – – –
SO
43
STRS Ohio
Ohio
$149K – – –
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$144K +$113K +13,040 New
ARTA
45
A.R.T. Advisors
New York
$136K +$107K +12,303 New
QSS
46
Quantitative Systematic Strategies
Florida
$133K +$105K +12,051 New
California Public Employees Retirement System
47
California Public Employees Retirement System
California
$111K +$86.9K +10,000 New
AIG
48
American International Group
New York
$97K -$634 -73 -0.8%
Wells Fargo
49
Wells Fargo
California
$86K +$61 +7 +0.1%
TRCT
50
Tower Research Capital (TRC)
New York
$76K +$58.9K +6,784 +22,613%
1
2
3

KNSA Hedge Fund Activity: Q4 2019 in Review

62 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Kiniksa Pharmaceuticals (KNSA) for Q4 2019, worth a combined $167M — up 26% from $132M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new KNSA positions and 10 closed out — a net gain of 8 holders — while 25 added to existing stakes and 11 trimmed.

The largest buyer was Ameriprise, adding an estimated $4.15M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.8M sold.

  • 62 institutional investors held Kiniksa Pharmaceuticals (KNSA) as of Q4 2019, up from 54 in Q3 2019.
  • Funds reported $167M of Kiniksa Pharmaceuticals stock for Q4 2019, up 26% quarter-over-quarter.
  • 18 funds opened new Kiniksa Pharmaceuticals positions in Q4 2019 and 10 closed out, a net change of +8 holders.
  • The largest Kiniksa Pharmaceuticals buyer in Q4 2019 was Ameriprise, an estimated $4.15M added.
  • The largest Kiniksa Pharmaceuticals seller in Q4 2019 was Deerfield Management, an estimated $10.8M sold.

Based on aggregated 13F filings for Q4 2019.